OPEN
© 2019 Joule Inc. or its licensors CMAJ OPEN, 7(1) E149
S
houlder pain is one of the most common musculoskel-
etal complaints among Canadian adults.
1
In the United
States over 18.9 million adults reported chronic shoul-
der pain, and it is responsible for over 4.5 million primary
care visits annually.
2–4
Shoulder impingement can account for
up to 85% of all shoulder complaints; it negatively affects
quality of life, results in substantial disability and impairs
physical function.
5
Impingement pathology not only is
responsible for a large health burden but also has a substan-
tial and growing economic impact.
6
It is estimated that
almost 300 000 surgical procedures for shoulder pathology
including impingement are performed annually in the US
alone, with the direct nancial burden estimated to be over
US$3 billion annually.
6,7
Most shoulder impingement is degenerative or chronic in
nature. Patients typically endorse pain with overhead tasks and
daily activities as well as discomfort at night. Conservative treat-
ment is often initially tried, which includes physiotherapy, sub-
acromial cortisone injection and oral anti-inammatory medica-
tions. When symptoms persist, surgical intervention involves
subacromial decompression and débridement.
8
Surgery may be
performed via open or arthroscopic means and surgical interven-
tion for impingement pathology has been increasing exponen-
tially.
9
Subacromial decompression has become one of the most
common orthopedic procedures and it is increasingly performed
in a minimally invasive outpatient manner with the use of
arthroscopy. Subacromial decompression surgery increased
sevenfold from 2000 to 2010 in the United Kingdom and four-
fold from 1996 to 2006 in the US.
6,10,11
Surgery for shoulder impingement: a systematic review and
meta-analysis of controlled clinical trials
Moin Khan MD MSc, Bashar Alolabi MD MSc, Nolan Horner MD, Asheesh Bedi MD,
Olufemi R. Ayeni MD PhD, Mohit Bhandari MD PhD
Competing interests: Asheesh Bedi reports personal fees from Arthrex
outside the submitted work. Olufemi Ayeni reports personal fees from
Smith & Nephew and ConMed outside the submitted work. Mohit
Bhandari reports personal fees from AgNovos Healthcare, Sanofi
Aventis, Smith & Nephew and Stryker and grants from DJ Orthopedics
and Ferring Pharmaceuticals outside the submitted work. No other
competing interests were declared.
This article has been peer reviewed.
Correspondence to: Moin Khan, [email protected]
CMAJ Open 2019. DOI:10.9778/cmajo.20180179
Background: Shoulder impingement is one of the most common nontraumatic upper limb causes of disability in adults. Our aim was
to evaluate the efficacy of surgical intervention in comparison with nonoperative or sham treatments in patients with shoulder
impingement in terms of both pain and functional outcomes.
Methods: We conducted a systematic review and meta-analysis of randomized controlled trials. Two reviewers independently
screened MEDLINE, Embase, PubMed and Cochrane databases for randomized controlled trials published from 1946 to July 19,
2018. A risk-of-bias assessment was conducted for all included studies, and outcomes were pooled using a random effects model.
The primary outcome was improvement in pain up to 2 years. Secondary outcomes were functional outcome scores reported in the
short term (≤ 1 yr) and long term (≥ 2 yr). Heterogeneity was assessed using the I
2
statistic. Functional outcome scores were pre-
sented along with minimal clinically important differences to provide clinical context for findings.
Results: Thirteen randomized controlled trials (n = 1062 patients) were included in this review. Eligible patients had a mean age of
48 (standard deviation ± 4) years and 45% were men. The pooled treatment effect of surgical intervention for shoulder impingement
did not demonstrate any benefit to surgery with respect to pain relief (mean difference –0.07, 95% CI –0.40 to 0.26) or short-term
functional outcomes (standardized mean difference –0.09, 95% confidence interval [CI] –0.27 to 0.08). Surgical intervention did result
in a small statistically significant but clinically unimportant improvement in long-term functional outcomes (standardized mean differ-
ence 0.23, 95% CI 0.06 to 0.41).
Interpretation: Evidence suggests surgical intervention has little, if any, benefit for impingement pathology in the middle-aged
patient. Further research is required to identify those patients who will reliably benefit from surgical intervention as well as optimal
conservative treatment strategies.
Abstract
Research
E150 CMAJ OPEN, 7(1)
OPEN
Research
Guidelines evaluating evidence for surgery remain incon-
clusive.
12,13
Earlier reviews did not include the ndings from
numerous recent randomized controlled trials.
14
The objec-
tive of this systematic review and meta-analysis was to evalu-
ate the efcacy of surgical intervention in comparison with
nonoperative or sham treatments in patients with shoulder
impingement in terms of both pain and functional outcomes.
Methods
This study was conducted according to the methods of the
Cochrane handbook
15
and is reported according to the
Preferred Reporting Items for Systematic Reviews and Meta-
Analyses (PRISMA) statement.
16
Eligibility criteria
The eligibility criteria were as follows: (a) studies that
involved patients over 18 years of age with shoulder impinge-
ment and (b) randomized controlled trials comparing opera-
tive treatment with nonoperative or sham surgical treatment.
No restriction was made regarding publication date, lan-
guage, presence or absence of co-interventions, type of non-
operative intervention, or length of follow-up. Case reports,
case series, prospective and retrospective cohort studies, edi-
torials, reviews and basic science and cadaveric studies were
excluded from this review.
Identification of trials
Multiple strategies were used to identify potential eligible tri-
als. MEDLINE, Embase and the Cochrane databases were
systematically searched in OVID from 1946 to July 19, 2018.
The search was performed by the primary author (M.K.); a
health sciences librarian experienced in the conduct of system-
atic reviews assisted in developing and performing the search.
MeSH and Emtree headings and subheadings were used in
various combinations and supplemented with free text to
increase sensitivity (Appendix 1, available at www.cmajopen.ca/
content/7/1/E149/suppl/DC1). The search strategy was
adapted in PubMed to search for articles e-published ahead of
print. Conference abstracts from recent major annual orthope-
dic and sports medicine conferences were reviewed. We also
consulted with experts in the eld, manually reviewed the ref-
erence lists of articles that fullled the eligibility criteria and
used the related articles feature in PubMed.
Screening and assessment of eligibility
All titles and abstracts were independently screened for eligibility
by 2 experienced reviewers (B.A., N.H.) using a piloted elec-
tronic database (Microsoft Excel). All discrepancies were resolved
by consensus involving discussion with the senior author (M.K.).
Duplicate articles were manually excluded. Both reviewers inde-
pendently reviewed the full text of all studies identied by title
and abstract screening to determine nal eligibility.
Assessment of risk of bias
Two reviewers independently performed duplicate outcome-
specific assessment of risk of bias using the Cochrane
Collaboration’s tool for assessing risk of bias.
15
The con-
dence in the estimate of the effect of the intervention for
quality of evidence was performed on the basis of the Grading
of Recommendations Assessment, Development and Evalua-
tion (GRADE) approach.
17
Extraction of data
Data were extracted independently and in duplicate by both
reviewers using a piloted electronic data extraction form.
Outcomes
The primary outcome was related to pain and secondary out-
comes were functional scores and postintervention complica-
tions. Functional outcomes were measured by various disease-
specic assessment scales and pain was assessed using a visual
analogue scale. Pain was reported up to 2 years after surgery.
Functional outcomes were dichotomized to short-term
(≤1 yr) and long-term (≥2 yr) data.
Statistical analysis
Interobserver agreement for the reviewers’ assessments of
study eligibility was calculated with Cohen’s κ coefcient.
18
Interobserver agreement for assessments of methodological
quality was calculated with the intraclass correlation coef-
cient. The κ and intraclass correlation coefcient were calcu-
lated using SPSS software (SPSS Inc.).
Outcome instruments that measured similar constructs were
summarized using standardized mean differences (SMDs).
19
The pooled estimate of effect for each outcome was obtained by
pooling individual trial SMDs weighted by sample size using the
random effects model based on the inverse variance method.
19
Scores were transformed when required to ensure that higher
scores indicated improved function in all cases.
19
When standard
deviations (SDs) were not available, they were calculated using
alternative measures or were otherwise estimated from trials
within the same comparison with similar scales, outcomes and
time periods.
19,20
Data were extracted from graphical representa-
tions when required. Statistical analysis and pooling of results
were performed on patients with complete data at follow-up.
When studies compared arthroscopic decompression with pla-
cebo surgery and nonoperative treatments, placebo and surgical
decompression were statistically compared.
SMD values were converted to Constant score values to
improve interpretability. The Constant score evaluates shoul-
der function by assessing both subjective and objective mea-
surements that include pain, activities of daily living, range of
motion and strength.
19
The score is commonly used in the
evaluation of rotator cuff pathology.
21
The minimal important
difference is estimated to be 10.4 points for the Constant
score for rotator cuff pathology.
22
A zone of no important dif-
ference based on the converted minimal important difference
was projected onto the forest plot to aid interpretability.
Outcomes were dichotomized to short-term results
(≤12 mo) and long-term data (≥2 yr). Sham surgery and non-
operative treatment were pooled given the similar underlying
conservative nature of the procedures. Complications were
tabulated and presented descriptively.
OPEN
CMAJ OPEN, 7(1) E151
Research
Forest plots were created with Review Manager 5.2 (Nor-
dic Cochrane Centre, Cochrane Collaboration).
Evaluation of heterogeneity and sensitivity analyses
Heterogeneity was quantied using the χ
2
test for heteroge-
neity and the I
2
statistic.
15
I
2
estimates the proportion of total
variability between studies due to heterogeneity rather than
chance alone. We considered I
2
less than 25% to indicate
low heterogeneity and I
2
greater than 75% to indicate con-
siderable heterogeneity.
15
A priori hypotheses were devel-
oped to explore both potential artifactual and real differ-
ences of treatment effect across trials. We planned for
subgroup analysis on the basis of the specific surgical
approach (open v. arthroscopic approaches) to evaluate
effect on treatment outcome. Sensitivity analyses were
planned for studies to investigate the effects of missing data,
comparisons between nonoperative and placebo treatments,
open and arthroscopic procedures, crossovers, and those trials
at high risk of bias.
Ethics approval
Because this was a systematic review and meta-analysis of
published studies, no ethics approval was required.
Results
Search results and study characteristics
The literature search identified 1699 potentially relevant
studies. Thirteen randomized controlled trials (n = 1062
patients) were eligible for inclusion in this review (Figure 1).
One non-English study was identied (in German), which was
translated.
23
The κ for overall agreement between reviewers
for the nal eligibility decision was 0.90 (95% condence
interval [CI] 0.80 to 1.00).
All 13 trials were performed in Europe. One study
24
involved multiple centres and the remainder were single-
centre trials. All of the included trials evaluated shoulder
impingement and excluded rotator cuff tears. Among the 13
studies, we identied 8 individual randomized controlled tri-
als, with the remaining studies including follow-up data of the
original patient cohort. Both Beard and colleagues and
Paavola and colleagues compared subacromial decompression
with (a) shoulder arthroscopy as a sham procedure and (b) no
treatment or exercise.
24,25
(Table 1). Six of the trials were pub-
lished in the last 5 years (range 1993–2018).
Conservative treatment arms involved physiotherapy, no
treatment, or exercise, with some trials including subacromial
cortisone injection or other medical analgesic treatment. Sur-
gical treatment for impingement consisted primarily of
arthroscopic subacromial decompression. Most of the
included studies provided measures of pain and functional
outcome scores, the most common being the Constant and
Neer shoulder scores. Sample sizes ranged from 42 to 313
patients. The mean age of patients was 48 (SD ± 4) yr, and
45% of them were men.
Loss to follow-up ranged from 4% to 35.7%. One trial
did not report crossover to the surgical treatment arm.
23
Of
the trials that did report crossovers, the percentages ranged
from 4% to 62% from conservative to surgical treatment, and
the mean crossover across trials was 21%. Crossover from
Articles identified by search
n = 1699
Titles and abstracts screened
n = 761
Duplicates excluded n = 938
Full texts screened
n = 10
Studies included
n = 13
Articles excluded n = 751
No impingement pathology n = 645
No operative intervention n = 23
No nonoperative comparison n = 62
Non RCT n = 16
Duplicates n = 5
Articles included after hand
search of references
n = 3
Figure 1: Selection of randomized controlled trials (RCTs) for inclusion in the meta-analysis.
E152 CMAJ OPEN, 7(1)
OPEN
Research
Table 1 (part 1 of 2): Studies included in the meta-analysis
Study, year Funding Country
Patient
characteristics
Treatment arm, no. of patients
and description of treatment*
Co-intervention
Major
outcome
measures
Crossover,
%
Loss to
follow-
up,
no. (%)
Mean
age,
yr
Male
sex,
% Conservative Surgical
Brox et al.,
1993
26
Non-
industry
Norway 48 53 50: Supervised
exercises
30: Placebo
laser
45: Arthroscopic
decompression
Postop physio
(twice wkly
increasing
resistance
exercises for
3–6 mo)
Neer score at
3, 6 mo; VAS
4 5 (4)
Peters et al.,
1997
23
Not
stated
Germany 58 64 40:
Physiotherapy
plus cortisone
injection
32: Arthroscopic
or open
decompression
Postop physio SSRS at 1,
2, 3, 4 yr
NR NR
Rahme et
al., 1998
27
Not
stated
Sweden 42 45 21:
Physiotherapy
21: Open
decompression
Postop physio VAS at 6, 12
mo
62 3 (7)
Brox et al.,
1999
28
Non-
industry
Norway 48 53 50: Supervised
exercises
30: Placebo
laser
45: Arthroscopic
decompression
Postop physio
(twice wkly
increasing
resistance
exercises for
3–6 mo)
Neer score at
6 mo, 2.5 yr;
VAS
33 15 (12)
Haahr et al.,
2005
29
Non-
industry
Denmark 44 31 45:
Physiotherapy
45: Arthroscopic
decompression
Postop physio
(periscapular
muscle and
rotator cuff
strengthening)
Constant
score at 3, 6,
12 mo; PRIM
score
13 6 (6.7)
Haahr et al.,
2006
30
Non-
industry
Denmark 44 31 45:
Physiotherapy
45: Arthroscopic
decompression
Postop physio
(periscapular
muscle and
rotator cuff
strengthening)
PRIM score
at 4–8 yr
24 11 (12)
Ketola et al.,
2009
31
Not
stated
Finland 47 37 70: Exercise 70: Arthroscopic
decompression
Postop physio
(supervised
therapy with
increasing
resistance for
rotator cuff
strengthening)
SDQ score at
2, 5 yr; VAS
score
19.3 6 (4.2)
Ketola et al.,
2013
32
Not
stated
Finland 47 37 70: Exercise 70: Arthroscopic
decompression
Postop physio
(supervised
therapy with
increasing
resistance for
rotator cuff
strengthening)
SDQ score at
2, 5 yr; VAS
score
21 31 (22.1)
Farfaras et
al., 2016
20
Not
stated
Sweden 50 49 34:
Physiotherapy
29: Arthroscopic
decompression
24: Open
decompression
Postop physio
(gradual
strengthening
exercises)
Constant
score at 2–3
yr; SF-36;
Watson and
Sonnebend
score; ROM
16 9 (10.3)
Ketola et al.,
2017
33
Not
stated
Finland 47 37 70: Exercise 70: Arthroscopic
decompression
Postop physio
(supervised
therapy with
increasing
resistance for
rotator cuff
strengthening)
SDQ score at
10 yr; VAS
21 50 (35.7)
OPEN
CMAJ OPEN, 7(1) E153
Research
conservative to surgical treatment was due to inadequate relief
of symptoms. Ketola and colleagues reported a 9.2% cross-
over from surgical to conservative treatment in which patients
cancelled surgery.
33
Six trials documented patients who
declined to participate; the primary reported reason for non-
participation was a strong preference for either surgical or
conservative intervention.
Risk of bias
Overall study quality was moderate (Figure 2).
20,23–34
We
found 3 trials to be of high quality and they included interven-
tions to blind outcome assessors and investigators where pos-
sible.
24,25,31–33
Agreement between reviewers in the assessment
of risk of bias was high (intraclass correlation coefcient 0.92,
95% CI 0.86 to 0.95). A summary of the ndings with respect
to outcomes is presented along with an evaluation of the qual-
ity of the evidence based on the Grading of Recommenda-
tions Assessment, Development and Evaluation (GRADE)
approach in Appendix 2 (available at www.cmajopen.ca/
content/7/1/E149/suppl/DC1).
17
Pain
Surgical intervention for shoulder impingement did not
improve pain at less than 2 years across 6 trials
23–26,29,32
involv-
ing a total of 631 patients (mean difference [MD] –0.07, 95%
CI –0.40 to 0.26) with low heterogeneity (p = 0.7, I
2
= 0%).
(Figure 3).
Subgroup analysis of only high-quality studies did not
change the results of our ndings (MD –0.06, 95% CI
–0.52 to 0.39).
24,25,32
Pooled findings from both of the
sham-controlled randomized trials also demonstrated no
benefit for arthroscopic decompression in comparison
with placebo surgery with respect to pain relief (MD 0.04,
95% CI –0.48 to 0.55).
24,25
Findings from trials comparing
surgery with exercise or physiotherapy also demonstrated
a consistent nding of no benet for surgical intervention
over nonoperative treatments (MD –0.15, 95% CI –0.57
to 0.28).
Short-term functional outcomes
Surgical intervention for shoulder impingement did not
improve short-term (≤1 yr) function across 5 trials
23–26,29
involving a total of 513 patients (SMD –0.09, 95% CI –0.27
to 0.08) with low heterogeneity (p = 0.2, I
2
= 28%) (Figure 4).
This is equivalent to an estimated Constant–Murley score
MD of 1.0 (95% CI –2.9 to 0.87). This assessment was
derived from the Constant score in 3 trials
24,25,29
and from the
Neer score and the Subjective Shoulder Rating Scale (SSRS)
in 1 trial each.
23,26
(Figure 4).
Sensitivity analysis related to open and arthroscopic
procedures did not change the review ndings with respect to
short-term functional outcomes when open procedures were
excluded (SMD –0.10, 95% CI –0.28 to 0.09) with moderate
heterogeneity (p = 0.1, I
2
= 46%).
Table 1 (part 2 of 2): Studies included in the meta-analysis
Study, year Funding Country
Patient
characteristics
Treatment arm, no. of patients*
and description of treatment
Co-intervention
Major
outcome
measures
Crossover,
%
Loss to
follow-
up,
no. (%)
Mean
age,
yr
Male
sex,
% Conservative Surgical
Beard et al.,
2018
24
Non-
industry
United
Kingdom
53 50 104: No
treatment
103: Sham
surgery
(diagnostic
arthroscopy)
106: Arthroscopic
decompression
Postop physio
(1–4 sessions)
Oxford
shoulder
score at 6,12
mo;
Constant–
Murley score;
PainDETECT
score; EQ5D;
VAS; HADS
25 48 (15)
Farfaras et
al., 2018
34
Not
stated
Sweden 50 49 34:
Physiotherapy
29: Arthroscopic
decompression
24: Open
decompression
Postop physio
(gradual
strengthening
exercises)
Constant
score at 10
yr; SF-36;
Watson and
Sonnebend
score; ROM
9 13 (14.9)
Paavola et
al., 2018
25
Non-
industry
Finland 50 30 71: Supervised
exercise
63: Sham
surgery
(diagnostic
arthroscopy)
59: Arthroscopic
decompression
Postop physio
(gradual
strengthening
exercises)
VAS;
Constant
score; simple
shoulder test;
15D
12 7 (3.6)
Note: EQ5D = EuroQol 5 dimensions score, HADS = Hospital Anxiety and Depression Score, postop physio = postoperative physiotherapy, SSRS = Subjective Shoulder
Rating Scale, PRIM = Project on Research and Intervention in Monotonous Work score, ROM = range of motion, SDQ = Shoulder Disability Questionnaire score,
SF-36 = Medical Outcomes Study 36-item Short Form, VAS = visual analogue scale; 15D = 15-dimensional score.
*The number of patients randomly assigned to each treatment arm.
E154 CMAJ OPEN, 7(1)
OPEN
Research
Long-term functional outcomes
Surgical intervention for rotator cuff disease demonstrated
a statistically but clinically unimportant benet compared
with nonoperative treatment in long-term functional out-
come (≥2 yr) across 6 trials
20,23,25,28,30,32
involving a total of
507 patients (SMD 0.23, 95% CI 0.06 to 0.41, I
2
= 0%).
This is equivalent to an estimated Constant–Murley score
MD of 2.51 (95% CI 0.65 to 4.47). This assessment was
derived from the Constant score in 2 trials
20,25
and from
the Neer,
28
Project on Research and Intervention in
Monotonous Work (PRIM),
30
Shoulder Disability Ques-
tionnaire (SDQ)
32
and SSRS
23
scores in 1 trial each. This
treatment effect did not exceed the threshold of patient
importance on the basis of minimal important difference
(Figure 5).
Adverse events
Two trials reported the presence of adverse events. The most
commonly reported adverse event was adhesive capsulitis. Beard
and colleagues reported 6 cases of adhesive capsulitis, 2 in each
of their treatment groups;
24
Paavola and colleagues reported 2
cases of adhesive capsulitis in patients undergoing exercise
treatment, 1 case in those undergoing diagnostic arthroscopy
and 3 cases in the subacromial decompression group.
25,28
There
was no significant difference in the odds of adverse events
between the groups receiving subacromial decompression and
placebo surgery (odds ratio 1.34, 95% CI 0.35 to 5.10).
24,25
Sensitivity analysis
We conducted a sensitivity analysis to evaluate the effects of
estimated missing SDs on long-term function through the
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
++
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
++
+
+
+
+
+
+
+
+
?
?
??
???
?
?
?
?
?
?
?
?
?
?
?
Study
Adequate
sequence
generation?
Allocation
Low risk Uncertain risk High risk
concealment? Blinding?
Incomplete
outcome data
assessed?
Free of
selective
reporting?
Free of other
bias?
Beard et al.
24
Brox et al.
26
Brox et al.
28
Farfaras et al.
20
Farfaras et al.
34
Haahr et al.
29
Haahr et al.
30
Ketola et al.
31
Ketola et al.
32
Ketola et al.
33
Peters et al.
23
Paavola et al.
25
Rahme et al.
27
Figure 2: Risk-of-bias assessment of randomized controlled trials included in the meta-analysis.
OPEN
CMAJ OPEN, 7(1) E155
Research
removal of studies that required estimated SDs. The results
were not signicant (SMD 0.24, 95% CI –0.02 to 0.50), with
no heterogeneity (p = 1.00, I
2
= 0%). Similarly, sensitivity
analysis with respect to pain outcomes did not change the
review ndings (MD –0.04, 95% CI –0.46 to 0.38) with low
heterogeneity (p = 0.29, I
2
= 19%). Sensitivity analysis on the
effect of substantial crossover (>15%) on the ndings did not
change the results with respect to long-term function (SMD
Study or subgroup
Brox et al.
26
Peters et al.
23
Haahr et al.
29
Ketola et al.
32
Beard et al.
24
Paavola et al.
25
Total (95% CI)
Heterogeneity:
χ
² = 3.00, df = 5 (p = 0.7); I² = 0%
Test for overall effect: z = 0.44 (p = 0.7)
Mean
2.5
2.8
2.4
2.5
2.44
2.3
SD
1.88
2.2
1.9
2.6
2.08
2.5
Total
41
26
41
68
67
59
302
Mean
2.5
2.8
2.6
2.9
2.12
2.8
SD
1.88
2.2
1.52
2.9
1.72
2.46
Total
49
36
43
66
72
63
329
Weight
17.9%
8.8%
20.0%
12.5%
26.8%
14.0%
100.0%
IV, fixed (95% CI)
0.00 (–0.78, 0.78)
0.00 (–1.11, 1.11)
–0.20 (–0.94, 0.54)
-–0.40 (–1.33, 0.53)
0.32 (–0.32, 0.96)
–0.50 (-–1.38, 0.38)
–0.07 (–0.40, 0.26)
Year
1993
1997
2005
2013
2018
2018
Surgical Conservative Mean difference Mean difference
IV, fixed (95% CI)
2
–1 0 1 2
Favours surgeryFavours conservative
Figure 3: Pooled visual analogue scale pain (<2 yr) outcomes of conservative and surgical treatment for shoulder impingement. Note: CI =
confidence interval, IV = inverse variance, SD = standard deviation.
Study or subgroup
Total (95% CI)
Test for overall effect: z = 1.03 (p = 0.3)
Mean
85.5
74
52.7
66.2
58.1
SD
6
15.8
14.7
19.9
16.6
Total
41
26
41
76
59
243
Mean
84.4
75
57
64.9
64.3
SD
7.4
16.9
14.4
17.2
16.7
Total
49
36
43
81
61
270
Weight
17.6%
11.9%
16.4%
30.9%
23.3%
100.0%
IV, fixed (95% CI) Year
1993
1997
2005
2018
2018
Surgery Conservative Std. mean differenceStd. mean difference
IV, fixed (95% CI)
–2 –1 0 1 2
Favours conservative Favours surgery
Brox et al.
26
Peters et al.
23
Haahr et al.
29
Beard et al.
24
Paavola et al.
25
0.16 (–0.26, 0.58)
–0.06 (–0.56, 0.44)
–0.29 (–0.72, 0.14)
0.07 (–0.24, 0.38)
–0.37 (–0.73, –0.01)
–0.09 (–0.27, 0.08)
Heterogeneity:
χ
² = 5.57, df = 4 (p = 0.2); I² = 28%
Figure 4: Pooled short-term (≤ 1 yr) functional outcomes of conservative and surgical treatment. Red lines show a zone of no important differ-
ence based on a minimal important difference of 10.4 points on the Constant–Murley score. Note: CI = confidence interval, IV= inverse vari-
ance. SD = standard deviation, Std. = standardized.
Study or subgroup
Peters et al.
23
Brox et al.
28
Haahr et al.
30
Ketola et al.
32
Farfaras et al.
20
Paavola et al.
25
Total (95% CI)
Heterogeneity:
χ
² = 2.08, df = 5 (p = 0.8); I² = 0%
Test for overall effect: z = 2.62 (p = 0.009)
Mean
79
93
26.9
75.8
66
77.9
SD
15.8
4.4
11.1
25
19.9
16.8
Total
32
31
39
68
19
59
248
Mean
74
94
24.6
67.2
61
73.7
SD
16.9
15.9
8.4
25
22.2
16.7
Total
40
33
40
66
21
59
259
Weight
14.0%
12.7%
15.6%
26.3%
7.9%
23.4%
100.0%
IV, fixed (95% CI)
0.30 (–0.17, 0.77)
–0.08 (–0.57, 0.41)
0.23 (–0.21, 0.67)
0.34 (0.00, 0.68)
0.23 (–0.39, 0.85)
0.25 (–0.11, 0.61)
0.23 (0.06, 0.41)
Year
1997
1999
2006
2013
2016
2018
Surgical Conservative Std. mean difference Std. mean difference
IV, fixed (95% CI)
–2 –1 0 1 2
Favours conservative Favours surgical
Figure 5: Pooled long-term (>2 yr) functional outcomes of conservative and surgical treatment. Red lines show a zone of no important differ-
ence based on a minimal important difference of 10.4 points on the Constant–Murley score. Note: CI = confidence interval, IV = inverse vari-
ance, SD = standard deviation, Std. = standardized.
E156 CMAJ OPEN, 7(1)
OPEN
Research
0.29, 95% CI 0.09 to 0.48), short-term function (SMD –0.16,
95% CI –0.37 to 0.05) or pain outcomes (MD –0.22, 95% CI
–0.60 to 0.17).
Interpretation
Surgical intervention for subacromial impingement syndrome
may have little if any benet with respect to pain and func-
tional outcomes in the short and long term in comparison
with nonoperative treatments such as exercise and physiother-
apy alone. Our ndings are strengthened by the inclusion of
randomized controlled trials, a sufciently large pooled sam-
ple of patients, condence intervals that excluded our thresh-
old of a minimal clinical importance and low heterogeneity
across studies.
The results of this systematic review and meta-analysis,
while similar, expand on the ndings of Dorrestijn and col-
leagues and Saltychev and colleagues, who evaluated random-
ized controlled trials comparing surgical and conservative
treatment for subacromial impingement syndrome.
35,36
Both
of those studies pooled results from 4 randomized controlled
trials and concluded that the available evidence does not sup-
port surgical intervention. However, the previous reviews had
substantial limitations. Dorrestijn and colleagues did not per-
form any statistical pooling of data and Saltychev and col-
leagues only pooled results for pain, with no assessment of
functional outcome. Additionally, both reviews were limited
by the fact that they included few trials and did not comment
on reported adverse events. The moderate heterogeneity (I
2
40%) in the study by Soltychev must limit condence in their
ndings; in contrast, we found no heterogeneity across the
studies included in our analysis.
The results of this review identied a small statistically sig-
nificant benefit for surgical intervention for subacromial
impingement in comparison with conservative treatment with
respect to improvement in long-term functional outcome.
This statistically signicant nding did not exceed the mini-
mal important difference. The minimal important difference
is the smallest change in a patient-reported outcome or score
that informed patients or proxies would perceive as important
or valuable enough to warrant a change in management when
considering the potential benets and harms of the interven-
tion.
37,28
The minimal important difference can vary across a
patient population and by disease; therefore, it is critical that
the minimal important difference used is appropriate to the
specic population of interest.
39
Kukkonen and colleagues
evaluated the minimal important difference of the Constant
score used in this review in patients with rotator cuff pathol-
ogy to be 10.4 points.
22
Although this tool has limitations it
provides the clinician with an aid to evaluate whether statisti-
cally signicant outcomes will be clinically meaningful.
38
The use of sham surgical procedures in which both groups
of patients undergo surgical treatment controls for the sub-
stantial potential for the placebo effect. This effect is based on
the expectations of a patient with respect to the perceived
effectiveness of a particular treatment.
40
Both Paavola and col-
leagues and Beard and colleagues performed sham-controlled
trials in which patients in 1 arm were randomly assigned to
undergo arthroscopic subacromial decompression and patients
in the other arm were randomly assigned to undergo diagnos-
tic arthroscopy. With both groups of patients undergoing sur-
gical intervention the placebo effect is controlled for, and
Paavola and colleagues reported that patients undergoing
sham surgery were no more likely to guess they underwent a
placebo procedure than those undergoing subacromial decom-
pression.
25
Both trials found no clinically signicant differences
between patients undergoing surgical decompression or pla-
cebo surgery with respect to pain or functional outcome
improvement.
Available instruments may not capture or detect clinically
signicant improvements in outcomes because of measurement
error related to limited sensitivity, limited reliability and/or
oor and ceiling effects.
41
Hessler and colleagues reported the
minimal detectable change for the Constant score to be 17
and 18 points for subacromial impingement syndrome and
rotator cuff tears, respectively, which is greater than the
minimal important difference.
41
Further study is required to
reliably assess outcomes for conservative and surgical
management of subacromial impingement syndrome.
The primary ndings of this review highlight the importance
of conservative treatment as the standard of care for shoulder
impingement. Given a lack of benet from surgical treatment,
physicians managing this clinical scenario should avoid surgical
intervention for subacromial impingement until conservative
measures have been exhausted. Recent systematic reviews evalu-
ating conservative treatment options have identied exercise, sub-
acromial cortisone injections and nonsteroidal anti-inammatory
drugs as having benet when compared with placebo or no treat-
ment in improving pain and functional outcomes.
43–45
An important finding of this review was the number of
patients who crossed over from conservative treatment to surgi-
cal intervention by the end of the study period. We found this
number to be variable, with a mean of 19% (range 4% to 62%)
across studies. Beard and colleagues reported that a primary
limitation of their study was lack of adherence to treatment
allocation not only with conservative to surgical crossovers but
also with surgical patients declining surgery given improvements
in pain while awaiting surgical intervention.
24
Per-protocol anal-
ysis in studies with substantial crossover may be underpowered,
but such studies that performed and reported not only
intention-to-treat analysis but also per-protocol analysis did
not find statistically and/or clinically significant differences
between analysis methods.
24,46,47
Additionally, in cases where
patients allocated to arthroscopic decompression or sham sur-
gery reported persistent symptoms and required unblinding to
consider reoperation, Paavola and colleagues found no signi-
cant differences in the frequency of unblindings between sham
and treatment groups.
Patient belief regarding the perceived efcacy of treatment
may play an important role in the success of an intervention.
Ketola and colleagues found that when patients were
informed of their allocated treatment, 65% in the surgical
group and only 28% in the conservative treatment group felt
full recovery would be possible with the intervention assigned.
33
OPEN
CMAJ OPEN, 7(1) E157
Research
Contreras and colleagues performed a case series of 49
patients and found difculty in predicting outcomes following
conservative treatment with respect to cuff pathology, age,
duration of symptoms or hand dominance.
48
Future research
to identify prognostic factors that will enable clinicians to
accurately determine which patients will benet from surgical
intervention will expedite care to those who may otherwise
fail conservative treatment.
Limitations
When data were unavailable, we estimated SDs on the basis of
similar studies or derived SDs from other provided measures
of variance. A sensitivity analysis confirmed that this was
unlikely to change the results of our review. Pooled analysis
combined various provided outcome measures; however,
given their construct similarities and the fact that published
data support comparability and correlation, we believe this
was reasonable.
21,42
Crossover between conservative and surgical
treatment was common in many trials; however, a sensitivity
analysis excluding trials with substantial crossover did not
identify any substantial change in the results of our review.
Conclusion
This systematic review and meta-analysis found moderate evi-
dence to suggest that there may be no clinically signicant
benet to surgical intervention for shoulder impingement in
comparison with nonoperative treatment for middle-aged
patients. Further research is required to identify those patients
who will reliably benet from surgical intervention as well as
optimal conservative treatment strategies.
References
1. Schopocher D, Taenzer P, Jovey R. The prevalence of chronic pain in Canada.
Pain Res Manag 2011;16:445-50.
2. Luime JJ, Koes BW, Hendriksen IJM, et al. Prevalence and incidence of shoul-
der pain in the general population; a systematic review. Scand J Rheumatol
2004;33:73-81.
3. Mather RC, Koenig L, Acevedo D, et al. The societal and economic value of
rotator cuff repair. J Bone Joint Surg Am 2013;95:1993-2000.
4. Andersson G; American Academy of Orthopaedic Surgeons. The burden of
musculoskeletal diseases in the United States: prevalence, societal and economic cost.
Rosemont (IL): American Academy of Orthopaedic Surgeons; 2008.
5. Ostör AJK, Richards CA, Prevost AT, et al. Diagnosis and relation to general
health of shoulder disorders presenting to primary care. Rheumatology (Oxford)
2005;44:800-5.
6. Colvin AC, Egorova N, Harrison AK, et al. National trends in rotator cuff
repair. J Bone Joint Surg Am 2012;94:227-33.
7. Beard D, Rees J, Rombach I, et al. The CSAW Study (Can Shoulder
Arthroscopy Work?) — a placebo-controlled surgical intervention trial
assessing the clinical and cost effectiveness of arthroscopic subacromial
decompression for shoulder pain: study protocol for a randomised controlled
trial. Trials 2015;16:210.
8. Wolf BR, Dunn WR, Wright RW. Indications for repair of full-thickness
rotator cuff tears. Am J Sports Med 2007;35:1007-16.
9. Thorpe A, Hurworth M, O’Sullivan P, et al. Rising trends in surgery for
rotator cuff disease in Western Australia. ANZ J Surg 2016;86:801-4.
10. Judge A, Murphy RJ, Maxwell R, et al. Temporal trends and geographical
variation in the use of subacromial decompression and rotator cuff repair of
the shoulder in England. Bone Joint J 2014;96-B:70-4.
11. Vitale MA, Arons RR, Hurwitz S, et al. The rising incidence of acromio-
plasty. J Bone Joint Surg Am 2010;92:1842-50.
12. Pedowitz RA, Yamaguchi K, Ahmad CS, et al. American Academy of Ortho-
paedic Surgeons clinical practice guideline on: optimizing the management
of rotator cuff problems. J Bone Joint Surg Am 2012;94:163-7.
13. Diercks R, Bron C, Dorrestijn O, et al. Guideline for diagnosis and treatment
of subacromial pain syndrome. Acta Orthop 2014;85:314-22.
14. Coghlan JA, Buchbinder R, Green S, et al. Surgery for rotator cuff disease.
Cochrane Database Syst Rev 2008;(1):CD005619.
15. Higgins JP. Cochrane handbook for systematic reviews of interventions. 5th ed. Vol.
5. Chichester (UK): Wiley-Blackwell; 2008.
16. Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for system-
atic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol
2009;62:1006-12.
17. Guyatt G, Oxman AD, Akl EA, et al. GRADE guidelines: 1. Introduction-
GRADE evidence proles and summary of ndings tables. J Clin Epidemiol
2011;64:383-94.
18. Fleiss JL, Levin B, Paik MC. Statistical methods for rates and proportions. 2nd ed.
New York: John Wiley and Sons; 1981.
19. Constant CR, Murley AH. A clinical method of functional assessment of the
shoulder. Clin Orthop Relat Res 1987; (214):160-4.
20. Farfaras S, Sernert N, Hallström E, et al. Comparison of open acromioplasty,
arthroscopic acromioplasty and physiotherapy in patients with subacromial
impingement syndrome: a prospective randomised study. Knee Surg Sports
Traumatol Arthrosc Off 2016;24:2181-91.
21. Gilbart MK, Gerber C. Comparison of the subjective shoulder value and the
Constant score. J Shoulder Elbow Surg 2007;16:717-21.
22. Kukkonen J, Kauko T, Vahlberg T, et al. Investigating minimal clinically
important difference for Constant score in patients undergoing rotator cuff
surgery. J Shoulder Elbow Surg 2013;22:1650-5.
23. Peters G, Kohn D. Medium-term clinical results after operative and non-
operative treatment of subacromial impingement. Unfallchirurg 1997; 100:
623-9.
24. Beard DJ, Rees JL, Cook JA, et al. Arthroscopic subacromial decompression
for subacromial shoulder pain (CSAW): a multicentre, pragmatic, parallel
group, placebo-controlled, three-group, randomised surgical trial. Lancet
2018;391:329-38.
25. Paavola M, Malmivaara A, Taimela S, et al. Subacromial decompression ver-
sus diagnostic arthroscopy for shoulder impingement: randomised, placebo
surgery controlled clinical trial. BMJ 2018;362:k2860.
26. Brox JI, Staff PH, Ljunggren AE, et al. Arthroscopic surgery compared with
supervised exercises in patients with rotator cuff disease (stage II impinge-
ment syndrome). BMJ 1993;307:899-903.
27. Rahme H, Solem-Bertoft E, Westerberg CE, et al. The subacromial
impingement syndrome. A study of results of treatment with special emphasis
on predictive factors and pain-generating mechanisms. Scand J Rehabil Med
1998;30:253-62.
28. Brox JI, Gjengedal E, Uppheim G, et al. Arthroscopic surgery versus super-
vised exercises in patients with rotator cuff disease (stage II impingement
syndrome): a prospective, randomized, controlled study in 125 patients with a
2 1/2-year follow-up. J Shoulder Elbow Surg 1999;8:102-11.
29. Haahr JP, Østergaard S, Dalsgaard J, et al. Exercises versus arthroscopic decom-
pression in patients with subacromial impingement: a randomised, controlled
study in 90 cases with a one year follow up. Ann Rheum Dis 2005;64:760-4.
30. Haahr JP, Andersen JH. Exercises may be as efcient as subacromial decom-
pression in patients with subacromial stage II impingement: 4-8-years’ follow-
up in a prospective, randomized study. Scand J Rheumatol 2006;35:224-8.
31. Ketola S, Lehtinen J, Arnala I, et al. Does arthroscopic acromioplasty provide
any additional value in the treatment of shoulder impingement syndrome?: A
two-year randomised controlled trial. J Bone Joint Surg Br 2009;91:1326-34.
32. Ketola S, Lehtinen J, Rousi T, et al. No evidence of long-term benets of
arthroscopicacromioplasty in the treatment of shoulder impingement syndrome:
ve-year results of a randomised controlled trial. Bone Joint Res 2013; 2:132-9.
33. Ketola S, Lehtinen JT, Arnala I. Arthroscopic decompression not recom-
mended in the treatment of rotator cuff tendinopathy: a nal review of a ran-
domised controlled trial at a minimum follow-up of ten years. Bone Joint J
2017;99-B:799-805.
34. Farfaras S, Sernert N, Rostgard Christensen L, et al. Subacromial decom-
pression yields a better clinical outcome than therapy alone: a prospective
randomized study of patients with a minimum 10-year follow-up. Am J Sports
Med 2018;46:1397-407.
35. Dorrestijn O, Stevens M, Winters JC, et al. Conservative or surgical treat-
ment for subacromial impingement syndrome? A systematic review. J Shoulder
Elbow Surg 2009;18:652-60.
36. Saltychev M, Äärimaa V, Virolainen P, et al. Conservative treatment or sur-
gery for shoulder impingement: systematic review and meta-analysis. Disabil
Rehabil 2015;37:1-8.
37. Johnston BC, Ebrahim S, Carrasco-Labra A, et al. Minimally important dif-
ference estimates and methods: a protocol. BMJ Open 2015;5:e007953.
38. Schünemann HJ, Guyatt GH. Commentary — goodbye M(C)ID! Hello
MID, where do you come from? Health Serv Res 2005;40:593-7.
39. Kim JK, Park MG, Shin SJ. What is the minimum clinically important differ-
ence in grip strength? Clin Orthop Relat Res 2014;472:2536-41.
40. Dowrick AS, Bhandari M. Ethical issues in the design of randomized trials: to
sham or not to sham. J Bone Jt Surg Am 2012;94(Suppl 1):7-10.
41. Henseler JF, Kolk A, van der Zwaal P, et al. The minimal detectable change
of the Constant score in impingement, full-thickness tears, and massive rota-
tor cuff tears. J Shoulder Elbow Surg 2015;24:376-81.
42. Tingart M, Bäthis H, Lefering R, et al. Constant score and Neer score. A com-
parison of score results and subjective patient satisfaction [article in German].
Unfallchirurg 2001;104:1048-54.
E158 CMAJ OPEN, 7(1)
OPEN
Research
43. Steuri R, Sattelmayer M, Elsig S, et al. Effectiveness of conservative interven-
tions including exercise, manual therapy and medical management in adults
with shoulder impingement: a systematic review and meta-analysis of RCTs.
Br J Sports Med 2017;51:1340-7.
44. Hawk C, Minkalis AL, Khorsan R, et al. Systematic review of nondrug, nonsurgi-
cal treatment of shoulder conditions. J Manipulative Physiol Ther 2017;40:293-319.
45. Shire AR, Stæhr TAB, Overby JB, et al. Specic or general exercise strategy for
subacromial impingement syndrome-does it matter? A systematic literature
review and meta analysis. BMC Musculoskelet Disord 2017;18:158.
46. Lambers Heerspink FO, van Raay JJAM, Koorevaar RCT, et al. Comparing
surgical repair with conservative treatment for degenerative rotator cuff tears: a
randomized controlled trial. J Shoulder Elbow Surg 2015;24:1274-81.
47. Moosmayer S, Lund G, Seljom US, et al. Tendon repair compared with phys-
iotherapy in the treatment of rotator cuff tears: a randomized controlled study
in 103 cases with a ve-year follow-up. J Bone Joint Surg Am 2014;96:1504-14.
48. Contreras F, Brown HC, Marx RG. Predictors of success of corticosteroid
injection for the management of rotator cuff disease. HSS J 2013;9:2-5.
Afliations: Division of Orthopaedic Surgery, Department of Surgery
(Khan, Alolabi, Horner, Ayeni, Bhandari), McMaster University, Hamil-
ton, Ont.; MedSport (Bedi), University of Michigan, Ann Arbor, Mich.;
Department of Clinical Epidemiology and Biostatistics (Bhandari),
McMaster University, Hamilton, Ont.
Contributors: Moin Khan and Mohit Bhandari conceived the study, and
Moin Khan designed it. Moin Khan, Bashar Alolabi and Nolan Horner
extracted the data and all authors contributed to the data analysis. Moin
Khan drafted the article and all other authors revised it critically for
important intellectual content. All authors gave nal approval of the ver-
sion to be published and agreed to act as guarantors of the work.
Supplemental information: For reviewer comments and the original
submission of this manuscript, please see www.cmajopen.ca/content/7/1/
E149/suppl/DC1.